A detailed history of Bedel Financial Consulting, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Bedel Financial Consulting, Inc. holds 29,495 shares of PFE stock, worth $788,106. This represents 0.12% of its overall portfolio holdings.

Number of Shares
29,495
Previous 27,973 5.44%
Holding current value
$788,106
Previous $782,000 9.08%
% of portfolio
0.12%
Previous 0.11%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$27.7 - $31.39 $42,159 - $47,775
1,522 Added 5.44%
29,495 $853,000
Q2 2024

Aug 05, 2024

BUY
$25.26 - $29.6 $1,768 - $2,072
70 Added 0.25%
27,973 $782,000
Q1 2024

May 07, 2024

BUY
$25.89 - $29.73 $750 - $862
29 Added 0.1%
27,903 $774,000
Q4 2023

Feb 08, 2024

SELL
$26.13 - $33.94 $41,834 - $54,337
-1,601 Reduced 5.43%
27,874 $802,000
Q3 2023

Feb 08, 2024

SELL
$32.09 - $37.51 $8,471 - $9,902
-264 Reduced 0.89%
29,475 $977,000
Q2 2023

Aug 10, 2023

BUY
$36.12 - $41.79 $56,744 - $65,652
1,571 Added 5.58%
29,739 $1.09 Million
Q1 2023

May 02, 2023

SELL
$39.39 - $51.28 $17,252 - $22,460
-438 Reduced 1.53%
28,168 $1.15 Million
Q4 2022

Feb 07, 2023

BUY
$41.75 - $54.5 $66,967 - $87,418
1,604 Added 5.94%
28,606 $1.47 Million
Q3 2022

Nov 08, 2022

BUY
$43.76 - $53.42 $81,218 - $99,147
1,856 Added 7.38%
27,002 $1.27 Million
Q2 2022

Aug 04, 2022

BUY
$46.53 - $55.17 $109,159 - $129,428
2,346 Added 10.29%
25,146 $1.32 Million
Q1 2022

Apr 19, 2022

BUY
$45.75 - $56.69 $35,502 - $43,991
776 Added 3.52%
22,800 $1.18 Million
Q4 2021

Jan 11, 2022

BUY
$41.32 - $61.25 $8,759 - $12,985
212 Added 0.97%
22,024 $1.3 Million
Q3 2021

Oct 12, 2021

SELL
$39.25 - $50.42 $4,788 - $6,151
-122 Reduced 0.56%
21,812 $938,000
Q2 2021

Aug 03, 2021

BUY
$35.91 - $40.68 $49,448 - $56,016
1,377 Added 6.7%
21,934 $859,000
Q1 2021

Apr 26, 2021

BUY
$33.49 - $37.77 $91,662 - $103,376
2,737 Added 15.36%
20,557 $745,000
Q4 2020

Feb 02, 2021

BUY
$33.47 - $42.56 $5,522 - $7,022
165 Added 0.93%
17,820 $656,000
Q3 2020

Oct 20, 2020

BUY
$31.75 - $37.25 $3,175 - $3,725
100 Added 0.57%
17,655 $648,000
Q2 2020

Jul 14, 2020

SELL
$30.12 - $36.54 $38,011 - $46,113
-1,262 Reduced 6.71%
17,555 $574,000
Q1 2020

May 06, 2020

BUY
$27.03 - $38.62 $10,325 - $14,752
382 Added 2.07%
18,817 $614,000
Q4 2019

Jan 28, 2020

SELL
$32.92 - $37.36 $147,777 - $167,709
-4,489 Reduced 19.58%
18,435 $722,000
Q3 2019

Oct 09, 2019

BUY
$32.49 - $42.13 $4,743 - $6,150
146 Added 0.64%
22,924 $824,000
Q2 2019

Aug 01, 2019

SELL
$36.98 - $41.52 $14,865 - $16,691
-402 Reduced 1.73%
22,778 $987,000
Q1 2019

May 02, 2019

BUY
$37.5 - $41.2 $75 - $82
2 Added 0.01%
23,180 $984,000
Q4 2018

Jan 28, 2019

SELL
$38.47 - $43.86 $26,236 - $29,912
-682 Reduced 2.86%
23,178 $1.01 Million
Q3 2018

Nov 01, 2018

BUY
$34.47 - $41.81 $22,543 - $27,343
654 Added 2.82%
23,860 $1.05 Million
Q2 2018

Jul 18, 2018

SELL
$32.98 - $35.16 $31,726 - $33,823
-962 Reduced 3.98%
23,206 $842,000
Q1 2018

May 03, 2018

BUY
$31.91 - $37.02 $95 - $111
3 Added 0.01%
24,168 $858,000
Q4 2017

Feb 06, 2018

BUY
$33.26 - $35.29 $803,727 - $852,782
24,165
24,165 $875,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Bedel Financial Consulting, Inc. Portfolio

Follow Bedel Financial Consulting, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bedel Financial Consulting, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bedel Financial Consulting, Inc. with notifications on news.